The U.S. Department of Justice disclosed Friday that Walmart will pay $50 million to settle a federal lawsuit accusing the retailer of unlawfully dispensing opioid prescriptions. The case, filed in December 2020 near the end of President Donald Trump’s first term, sought billions in civil penalties.

Allegations and legal background

The Justice Department claimed Walmart repeatedly violated the Controlled Substances Act since 2013 by ignoring “red flags” and failing to report suspicious opioid prescriptions. According to the filing, some Walmart compliance officials were aware that certain prescribers operated as “pill mills” yet still filled their orders.

Settlement terms

While Walmart did not admit liability, the settlement includes tighter oversight of pharmacists and a hotline for employees and patients to report suspected illegal dispensing. Associate Attorney General Stanley Woodward said the agreement demonstrates the department’s commitment to putting Americans’ flourishing first.

Financial context

Walmart reported net income of $11.7 billion for the six months ending July 31. The $50 million payout is far below the billions the Justice Department originally indicated Walmart could owe. In 2022, Walmart settled thousands of state and local lawsuits for $3.1 billion over similar pharmacy practices. Shares closed up 46 cents at $103.09 following the announcement.

Broader opioid litigation

The case was one of the Justice Department’s most significant actions against a single company in the opioid epidemic. Other major retailers, including CVS and Walgreens, have reached larger settlements. Purdue Pharma pleaded guilty to criminal charges in 2020, and drug wholesaler Cencora (formerly AmerisourceBergen) also faced federal scrutiny.

More than 905,000 Americans died from opioid overdoses between 1999 and 2025, according to the CDC, though annual deaths have begun to decline after 2022.

Original reporting: Texarkana Gazette — read the source article.